Lv2
120 积分 2024-02-04 加入
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence
10天前
已完结
Comparison in Patients < 75 Years of Age - Versus – Those > 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the Prospective Multicenter German LAARGE Registry)
1年前
已关闭
Comparison in Patients < 75 Years of Age - Versus – Those > 75 Years on One-year-Events With Atrial Fibrillation and Left Atrial Appendage Occluder (From the Prospective Multicenter German LAARGE Registry)
1年前
已完结
Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥75 Years
1年前
已完结
Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis
1年前
已完结
Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation
1年前
已完结
Randomized Trial of Surgical Left Atrial Appendage Closure: Protection Against Cerebrovascular Events
1年前
已关闭
Antithrombotic Management After Left Atrial Appendage Closure: Current Evidence and Future Perspectives
1年前
已完结
皖公网安备34019202002308
